European vs 2015-World Health Organization clinical molecular and pathological classification of myeloproliferative neoplasms

doi:10.5315/wjh.v4.i3.16

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (17319)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-20) series, Tables (1-12) series.

Item

Count

PDF

881

WORD

492

HTML

9415

Figures (1-20)

728

Tables (1-12)

395

Sum=11911

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

902

Download

1869

Sum=2771

Publishing Process of This Article

Item

Count

Browse

1280

Download

1357

Sum=2637

Aug 6, 2015 (publication date) through Jan 24, 2025

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Hematology

ISSN

2218-6204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hematol. Aug 6, 2015; 4(3): 16-53
Published online Aug 6, 2015. doi: 10.5315/wjh.v4.i3.16

Full Size Figure Download Figure

Figure 12 Sequential stages of essential thrombocythemia 1995-2004, prodromal polycythemia vera 2004-2005 and overt polycythemia vera 2006, with a complete hematological response (complete hematological responses, case 6, Table 9, Figure 11) and subsequent complete hematological responses of interferon for 6 years at age of 72 years anno 2013.

Citation: Michiels JJ, Valster F, Wielenga J, Schelfout K, Raeve HD. European vs 2015-World Health Organization clinical molecular and pathological classification of myeloproliferative neoplasms. World J Hematol 2015; 4(3): 16-53
URL: https://www.wjgnet.com/2218-6204/full/v4/i3/16.htm
DOI: https://dx.doi.org/10.5315/wjh.v4.i3.16